Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229892 · ClinicalTrials.gov registry record
Incisions for Cardiac Surgery
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 90
- Enrollment target
NCT00229892: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00229892 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00229892 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose is to evaluate the investigators' length of incisions based on patient weight, operative times, hospital lengths of stay, pain medicine requirements, complications and costs. These data will lead to a new minimally invasive standard of care without a reduction in outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-02 |
| Est. Completion | 2006-09 |
Why NCT00229892 stopped before completion
NCT00229892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00229892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00229892 about?
NCT00229892 is a clinical study titled "Incisions for Cardiac Surgery". The purpose is to evaluate the investigators' length of incisions based on patient weight, operative times, hospital lengths of stay, pain medicine requirements, complications and costs. These data will lead to a new minimally invasive standard of care without a reduction in outcomes.
What is the current status of trial NCT00229892?
This trial is currently terminated. The enrollment target is 90 participants. The study started on 2005-02. Estimated completion is 2006-09.
Who is sponsoring clinical trial NCT00229892?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia